COVID-19: all 7,774 studies

Page 63 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety StudyActive, not recruitingNCT04469491Phase 2
• Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19Status unknownNCT04469179Phase 1
• Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19Status unknownNCT04469153
• Tofacitinib in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04469114Phase 3
• REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumoniaCompletedNCT04468971Phase 1
• Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?CompletedNCT04468802
• To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 PatientsStatus unknownNCT04468646Phase 3
• VRQOL in Cataract Patients During the COVID-19 PandemicStatus unknownNCT04468308
• The Heart Hive COVID-19 StudyCompletedNCT04468256
• The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19Status unknownNCT04468139Phase 4
• Antiviral Agents Against COVID-19 InfectionCompletedNCT04468087Phase 2/3
• Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical VentilationCompletedNCT04468035
• Treatment of Critically Ill Patients With Covid-19 With Convalescent PlasmaCompletedNCT04468009Phase 2
• Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19WithdrawnNCT04467151Phase 2
• Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19Status unknownNCT04467047Phase 1
• Covid-19 Rapid Diagnostic Tests on Blood DropCompletedNCT04467008
• Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) InfectionCompletedNCT04466982
• Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson PatientsCompletedNCT04466839
• Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) PneumoniaActive, not recruitingNCT04466683Phase 2
• Hemostasis in COVID-19: an Adaptive Clinical TrialStatus unknownNCT04466670Phase 2
• Antioxidant Therapy for COVID-19 StudyWithdrawnNCT04466657Not applicable
• COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics)CompletedNCT04466644
• Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)CompletedNCT04466540Phase 4
• Cross-sectional Study of COVID-19 Infection in Hospital Health PersonnelCompletedNCT04466462
• Perceptions of Undergraduate Students and Teaching Staff on Online TeachingSuspendedNCT04466371
• Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19WithdrawnNCT04466280Not applicable
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb TrialCompletedNCT04466241Phase 2/3
• Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 PatientsStatus unknownNCT04465981
• Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19Status unknownNCT04465695Phase 2
• Hypertonic Saline for COVID-19 SymptomsStatus unknownNCT04465604Not applicable
• Arrhythmic Manifestations and Management in Hospitalized COVID-19 PatientsCompletedNCT04465552
• Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19CompletedNCT04465513Not applicable
• Characteristics of Critically Ill COVID 19 PatientsStatus unknownNCT04465058
• Favipiravir Therapy in Adults With Mild COVID-19CompletedNCT04464408Phase 2/3
• Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 PatientsCompletedNCT04464395Phase 1
• COVID - AirPollutionCompletedNCT04463862
• Effects of COVID-19 Infection on Beta-cell Function in Euglycemic PatientsCompletedNCT04463849Not applicable
• Covid-19 in Pregnancy: a French Population-based Cohort of Women and NewbornsCompletedNCT04463758
• COVID19 Severity Prediction and Health Services Research EvaluationCompletedNCT04463706
• Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 EpidemicCompletedNCT04463628
• Desidustat in the Management of COVID-19 PatientsCompletedNCT04463602Phase 2
• Study of COVID-19 DNA Vaccine (AG0301-COVID19)CompletedNCT04463472Phase 1/2
• Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in ChinaStatus unknownNCT04463433Not applicable
• Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19Status unknownNCT04463420Not applicable
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)Status unknownNCT04463264Phase 2/3
• Emergency Department (ED) Self-Monitoring Pilot COVID-19WithdrawnNCT04462783Not applicable
• SCIL-1Ra in COVID-19 Feasibility & PK/PDTerminatedNCT04462757Phase 2
• Reduction of COVID 19 Transmission to Health Care ProfessionalsCompletedNCT04462627Not applicable
• Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19Active, not recruitingNCT04462393
• Northeast COVID-19 and Pregnancy Study GroupActive, not recruitingNCT04462367
• IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control StudyStatus unknownNCT04462120
• Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCsStatus unknownNCT04461925Phase 1/2
• Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare WorkersStatus unknownNCT04461379Phase 3
• Efficacy and Safety of Sirolimus in COVID-19 InfectionStatus unknownNCT04461340Phase 2
• COVID-19 Vaccine Messaging, Part 1CompletedNCT04460703Not applicable
• Coagulation Changes Associated With COVID-19 InfectionCompletedNCT04460664
• PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention TrialCompletedNCT04460651Phase 3
• Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 PandemicStatus unknownNCT04460547
• Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 PandemicCompletedNCT04460469
• Forecast Number of Covid-19 Cases WorldwideCompletedNCT04460274
• COVID-19 Follow up Intensive Care StudiesCompletedNCT04460170
• Lanadelumab in Participants Hospitalized With COVID-19 PneumoniaWithdrawnNCT04460105Phase 1
• Covid-19 Breath TestCompletedNCT04459962Not applicable
• Respiratory Physiotherapy in Severe COVID-19 PatientsCompletedNCT04459819
• A Study of Combination Therapies to Treat COVID-19 InfectionWithdrawnNCT04459702Phase 2
• Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 PneumoniaStatus unknownNCT04459676Phase 2
• COVID-19 Surveillance Based on Smart Wearable DeviceCompletedNCT04459637
• Sparing in Neuromuscular Blockade in COVID 19 ICUCompletedNCT04459533
• Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially DistanceCompletedNCT04459520Not applicable
• Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 PandemicCompletedNCT04459455Not applicable
• Psychiatric Disturbances and COVID-19 InfectionCompletedNCT04459403
• Association of Comorbidities With COVID19Status unknownNCT04459390
• PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErsStatus unknownNCT04459351
• Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19CompletedNCT04459325Phase 3
• National Covid-19 Surveillance PhysiciansStatus unknownNCT04459312
• The Nitazoxanide Plus Atazanavir for COVID-19 StudyTerminatedNCT04459286Phase 2
• Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 InfectionCompletedNCT04458519Not applicable
• Convalescent Plasma in Pediatric COVID-19CompletedNCT04458363Early Phase 1
• SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)CompletedNCT04458337
• A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) PatientsTerminatedNCT04458298Phase 2
• Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 PandemicStatus unknownNCT04458246Not applicable
• Compensatory Reserve Index (CRI) for Management of COVID-19TerminatedNCT04457817
• Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19Status unknownNCT04457726Phase 1/2
• Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 PatientsStatus unknownNCT04457609Phase 1
• Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19CompletedNCT04457349Not applicable
• Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare ProfessionalsCompletedNCT04456595Phase 3
• Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)CompletedNCT04456556
• Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen SupplementationCompletedNCT04456452Phase 1
• Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)No longer availableNCT04456439
• Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19Active, not recruitingNCT04456361Early Phase 1
• Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)WithdrawnNCT04456088Phase 2
• Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19Status unknownNCT04456075
• Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 PandemicCompletedNCT04456062Not applicable
• Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1TerminatedNCT04456049Phase 2
• Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute CareStatus unknownNCT04456036
• COVID-19 in ART: Perception and ExperienceCompletedNCT04456010
• Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last YearWithdrawnNCT04455958Phase 2
• Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 LinkedStatus unknownNCT04455347
• COVID-19 and ChilblainsCompletedNCT04455308Not applicable
• Inflammatory Regulation Effect of NAC on COVID-19 TreatmentStatus unknownNCT04455243Phase 3

← COVID-19 overview